Prediction of survival in patients with thin melanoma: Results from a multi-institution study

Journal of Clinical Oncology

Volumn 32, Issue 23, 2014, Pages 2479-2485

  Maurichi, Andrea ^a   Miceli, Rosalba ^a   Camerini, Tiziana ^a   Mariani, Luigi ^a   Patuzzo, Roberto ^a   Ruggeri, Roberta ^a   Gallino, Gianfranco ^a   Tolomio, Elena ^a   Tragni, Gabrina ^a   Valeri, Barbara ^a   Anichini, Andrea ^a   Mortarini, Roberta ^a   Moglia, Daniele ^a   Pellacani, Giovanni ^b   Bassoli, Sara ^b   Longo, Caterina ^b   Quaglino, Pietro ^c   Pimpinelli, Nicola ^d   Borgognoni, Lorenzo ^d   Bergamaschi, Daniele ^e   Harwood, Catherine ^e   Zoras, Odysseas ^f   Santinami, Mario ^a   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c University Hospital of Turin   (Italy)

^d SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^f UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRESLOW THICKNESS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MITOSIS RATE; MULTICENTER STUDY; NOMOGRAM; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURVIVAL PREDICTION; THICKNESS; THIN MELANOMA; ULCER; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; EUROPE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RECURRENT DISEASE; RISK ASSESSMENT; SKIN TUMOR; SURVIVAL;

ADULT; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NOMOGRAMS; PROGNOSIS; RECURRENCE; RISK ASSESSMENT; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84905855992     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.2340     Document Type: Article

References (30)

1. Parkin DM, Ferlay J, Curado MP, et al: Fifty years of cancer incidence: CI5 I-IX. Int J Cancer 127:2918-2927, 2010
2. Gimotty PA, Elder DE, Fraker DL, et al: Identification of high-risk patients among those diagnosed with thin cutaneous melanomas. J Clin Oncol 25:1129-1134, 2007 (Pubitemid 46596766)
3. Balch CM, Gershenwald JE, Soong SJ, et al: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27:6199-6206, 2009
4. Balch CM, Murad TM, Soong SJ, et al: Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 43:883-888, 1979 (Pubitemid 9163616)
5. Kalady MF, White RR, Johnson JL, et al: Thin melanomas: Predictive lethal characteristics from a 30-year clinical experience. Ann Surg 238:528-535, 2003
6. Kesmodel SB, Karakousis GC, Botbyl JD, et al: Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 12:449-458, 2005 (Pubitemid 40884259)
7. Wong SL, Brady MS, Busam KJ, et al: Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol 13:302-309, 2006 (Pubitemid 43255912)
8. Yonick DV, Ballo RM, Kahn E, et al: Predictors of positive sentinel lymph node in thin melanoma. Am J Surg 201:324-327, 2011
9. Wong SL, Balch CM, Hurley P, et al: Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol 30:2912-2918, 2012
10. Coit DG, Andtbacka R, Anker CJ, et al: Melanoma, version 2.2013: Featured updates to the NCCN guidelines. J Natl Compr Canc Netw 11:395-407, 2013
11. Marubini E, Valsecchi MG: Analysing Survival Data for Clinical Trials and Observational Studies. Chichester, United Kingdom, John Wiley & Sons, 1995
12. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
13. Schoenfeld D: Partial residuals for the proportional hazards regression model. Biometrika 69:239-241, 1982
14. Akaike H: Information theory and an extension of the Maximum Likelihood principle, in Csáki F, Petrov BN (eds): Information Theory: Proceedings of the 2nd International Symposium. Budapest, Hungary, Akadémiai Kiedo, 1973
15. Harrell FE Jr, Lee KL, Mark DB: Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361-387, 1996 (Pubitemid 26072233)
16. Efron B, Tibshirani RJ: An Introduction to the Bootstrap. New York, NY, Chapman and Hall, 1993
17. Durrleman S, Simon R: Flexible regression models with cubic splines. Stat Med 8:551-561, 1989 (Pubitemid 19116001)
18. Sondak VK, Taylor JM, Sabel MS, et al: Mitotic rate and younger age are predictors of sentinel lymph node positivity: Lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11:247-258, 2004 (Pubitemid 40486764)
19. Murali R, Haydu LE, Quinn MJ, et al: Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma. Ann Surg 255:128-133, 2012
20. Han D, Yu D, Zhao X, et al: Sentinel node biopsy is indicated for thin melanomas ≥ 0.76 mm. Ann Surg Oncol 19:3335-3342, 2012
21. Venna SS, Thummala S, Nosrati M, et al: Analysis of sentinel lymph node positivity in patients with thin primary melanoma. J Am Acad Dermatol 68:560-567, 2013
22. Xu X, Chen L, Guerry D, et al: Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma. Clin Cancer Res 18:229-237, 2012
23. Egger ME, Gilbert JE, Burton AL, et al: Lymphovascular invasion as a prognostic factor in melanoma. Am Surg 77:992-997, 2011
24. Massi D, Franchi A, Borgognoni L, et al: Thin cutaneous malignant melanomas (< or = 1.5 mm): Identification of risk factors indicative of progression. Cancer 85:1067-1076, 1999 (Pubitemid 29115585)
25. McClain SE, Shada AL, Barry M, et al: Outcome of sentinel lymph node biopsy and prognostic implications of regression in thin malignant melanoma. Melanoma Res 22:302-309, 2012
26. Leiter U, Buettner PG, Eigentler TK, et al: Prognostic factors of thin cutaneous melanoma: An analysis of the central malignant melanoma registry of the German Dermatological Society. J Clin Oncol 22:3660-3667, 2004 (Pubitemid 41095204)
27. Burton AL, Gilbert J, Farmer RW, et al: Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Am Surg 77:1009-1013, 2011
28. Murali R, Haydu LE, Long GV, et al: Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Ann Surg Oncol 19:1782-1789, 2012
29. Green AC, Baade P, Coory M, et al: Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia. J Clin Oncol 30:1462-1467, 2012
30. Faries MB, Steen S, Ye X, et al: Late recurrence in melanoma: Clinical implications of lost dormancy. J Am Coll Surg 217:27-34, 2013